Onconetix, Inc.
USD1.03
+0.08 (+7.93%)
CEO
David Allan White
IPO Date
2022-02-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.93
Prev. Close
$0.95
Day Low
$0.91
Day High
$1.05
52W Low
$0.88
52W High
$270.00
Market Cap
$0.00B
Volume
0.24M
| -5.2 |
| 31 Dec 2023 | FY | -1927.9% | -63986.5% | 667.8% | -42.7% | -1.76 | 0.34 | -15.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -59.9% | -51.0% | 0.00 | 6.69 | -176.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -236.2% | -110.8% | 0.00 | 1.88 | -32470.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -33.8% | -33.2% | 0.00 | 66.94 | -69375.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -13.7% | -13.5% | 0.00 | 79.98 | -135005.6 |
| 11.3 |
| 30 Sept 2025 | Q3 | 88.6% | -2892.7% | -260.3% | -44.6% | 0.05 | 0.08 | -21.8 |
| 30 Jun 2025 | Q2 | 66.2% | -2227.8% | -40.1% | -12.4% | 1.48 | 0.07 | -49.9 |
| 31 Mar 2025 | Q1 | 45.1% | -8408.8% | -189.2% | -45.5% | 2.00 | 0.17 | -7.3 |
| 31 Dec 2024 | Q4 | 92.7% | -4134.7% | -306.3% | -104.5% | 0.98 | 0.05 | -11.0 |
| 30 Sept 2024 | Q3 | 25.9% | -940.7% | -11.3% | -6.2% | 0.30 | 0.06 | -77.6 |
| 30 Jun 2024 | Q2 | 14.3% | -2029.8% | -50.3% | -24.1% | 0.54 | 0.10 | -10.7 |
| 31 Mar 2024 | Q1 | 27.0% | -1587.4% | 51.6% | -14.8% | -0.72 | 0.29 | -13.6 |
| 31 Dec 2023 | Q4 | -1941.8% | -38229.5% | 399.0% | -25.5% | -1.76 | 0.34 | -8.7 |